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Abstract
Background: 5-Azacytidine (5-AZA), a DNA methyl transferase inhibitor, is a clinically used epigenetic drug for
cancer therapy. Recently, we have shown that 5-AZA upregulates ten-eleven translocation (TET) protein expression
in hepatocellular carcinoma (HCC) cells, which induce active demethylation. Vitamin C facilitates TET activity and
enhances active demethylation. The aim of this study is to investigate whether vitamin C is able to enhance the
effect of 5-AZA on active demethylation and to evaluate its consequence in HCC cell lines.
Methods: HCC cell lines (Huh7 and HLE) were treated with 5-AZA and vitamin C. After 48 h of treatment,
viability (resazurin conversion), toxicity (lactose dehydrogenase (LDH) release), and proliferation ((proliferating
cell nuclear antigen (PCNA)) of single- and combined-treated cells were assessed. The effect of the treatment
on 5-hydroxymethylcytosine (5hmC) intensity (immunofluorescence (IF) staining), TET, Snail, GADD45B, and P21
mRNA (real-time PCR) and protein expression (Western blot) were investigated.
Results: Our results indicated that vitamin C enhances the anti-proliferative and apoptotic effect of 5-AZA in
HCC cell lines. By further analyzing the events leading to cell cycle arrest, we have shown for the first time in
HCC that the combination of 5-AZA and vitamin C leads to an enhanced downregulation of Snail expression,
a key transcription factor governing epithelial-mesenchymal transition (EMT) process, and cell cycle arrest.
Conclusions: We conclude that when combined with 5-AZA, vitamin C enhances TET activity in HCC cells,
leading to induction of active demethylation. An increase in P21 expression as a consequence of downregulation of Snail
accompanied by the induction of GADD45B expression is the main mechanism leading to cell cycle arrest in HCCs.
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Background
Hepatocellular carcinoma (HCC) is the most common
adult liver malignancy that shows relatively poor progno-
sis and rapid progression [1, 2]. It is now established that
tumor cells undergo various epigenetic modifications, par-
ticularly DNA hypermethylation, that could lead to an im-
balance in regulation of pro- and anti-apoptotic genes,
which is attributed as one of the important factors in the
progression and treatment of cancer [1, 3].
Recently, demethylation of 5-methylcytosine (5mC) to 5-
hydroxymethyl cytosine (5hmC) was shown to be mediated
by ten-eleven translocation (TET) proteins [4–6]. Since
hypermethylation of promoters of tumor suppressor genes
has been identified as one of the principal factors support-
ing cancer development, demethylation agents have now
become the main focus of molecular-targeted therapeu-
tics. Various in vitro studies have shown that 5-
azacytidine (5-AZA), a potent DNA methyl transferase
inhibitor (DNMTi), leads to re-expression of silenced
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genes and altered expression of genes involved in
tumor suppression [7]. However, a very few studies
have been published to understand the mode of action
of 5-AZA. Recently, our lab clearly demonstrated that
5-AZA modulates the expression of genes through in-
duction of TET2 and TET3, improving 5hmC gener-
ation in HCC and inhibiting cells proliferation [8].
All TET proteins contain a catalytic domain which
binds to Fe2+ and 2-oxoglutarate to mediate oxidation of
5mC to 5hmC in DNA [4]. Vitamin C plays a central role
in the conversion of 5mC to 5hmC by enhancing the cata-
lytic activity of TET dioxygenases [9, 10]. In addition, re-
cent reports point to the important role of vitamin C in
modulating mesenchymal-epithelial transition (MET) by
regulating TET1 [11] and also in inducing cell death via
epigenetic modification in melanoma cells [12]. Therefore,
vitamin C might be an important factor in reducing the
risk of promoter hypermethylation supporting the main-
tenance of the 5hmC state and thus might play a major
role in the epigenetic regulation [9, 11, 13, 14].
Transition from epithelial to mesenchymal (EMT) state is
partially mediated by Snail expression, which is considered
as a hallmark of cancer progression [15–17]. Transient Snail
expression suppresses the epithelial marker E-cadherin
whose downregulation is directly associated with tumor in-
vasion and metastasis in HCC [18–20]. In addition to the
control of EMT, Snail as a major transcriptional repressor is
also involved in the regulation of cell cycle progression and
in conferring resistance to programmed cell death [21].
Several reports have shown that 5-AZA induces cell
cycle arrest and cell death in tumor cells [22, 23] by alter-
ing the epigenetic state, but the details of 5-AZA-induced
cell cycle arrest in HCC are not completely understood.
Accumulating evidences also point to the significance of
epigenetics in regulating EMT in cancer [reviewed in
[24]]. A recent report shows MET in trophoblast cells by
induction of epithelial markers when treated with a 5-
AZA analog [25]. However, the effect of 5-AZA on Snail
expression and the downstream pathways is not yet
known. Hence, we have probed into the changes in gene
expression of Snail which could possibly link EMT/MET
and cell cycle arrest mediated by 5-AZA. Furthermore, we
have also questioned if vitamin C as an epigenetic modi-
fier could enhance the effect of 5-AZA in inducing cell
death which probably could be explored as a possible
combination therapy in HCC.
Our results have shown that 5-AZA induces cell cycle
arrest by downregulating Snail and upregulating Gadd45
which was further enhanced by vitamin C.
Methods
Cell culture reagents, antibodies, and chemicals
DMEM medium and cell culture supplements were pur-
chased from Sigma (Steinheim, Germany). Cell culture
plastics, phosphate-buffered saline (PBS), and fetal calf
serum (FCS) were purchased from PAA Laboratories
GmbH (Pasching, Austria). DNase I (RNase-free) and First
Strand cDNA Synthesis Kit were purchased from Fermen-
tas (Ontario, Canada). 5-AZA and L-ascorbic acid 2-
phosphate were obtained from Sigma-Aldrich (Steinheim,
Germany). All other chemical compounds were purchased
from Carl Roth (Karlsruhe, Germany). 5-hmC (39769)
mouse mAB was purchased from Active Motif (Carlsbad,
CA, USA). Proliferating cell nuclear antigen (PCNA)
(ab92552) rabbit mAB was obtained from Abcam (Cam-
bridge, UK). Corresponding secondary antibodies goat
anti-rabbit Alexa 555 and goat anti-mouse 488 were ac-
quired from Invitrogen (Carlsbad, CA, USA). Anti TET2
(SAB3500711), anti TET3 (SAB2700682), and anti glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) (G9545)
antibodies were used from Sigma (Munich, Germany).
GADD45B (SC33172) rabbit mAB was from Santa Cruz,
and Snail (3879) rabbit mAB, E-cadherin (14472) mouse
mAB, p21 (2947) rabbit mAB, cyclin-B1 (4138) rabbit
mAB, and HRP-linked anti-mouse and anti-rabbit IgG
secondary antibody were purchased from Cell Signal-
ing (Beverly, MA, USA).
Cell culture and treatment
HLE and Huh7 cell lines were purchased from ATCC
and cultured as published previously [8]. The HCC cell
lines were plated onto 6-, 24-, or 96-well plates. Twenty-
four hours after plating, the cells were incubated with
10 μM of 5-AZA and 1 mM of vitamin C (L-ascorbic acid
2-phosphate) for 48 h. 5-AZA and vitamin C were admin-
istrated at the same time. The absence of mycoplasma
contamination was regularly tested using a commercially
available test (Venor®GeMtest, Minerva Biolabs GmbH,
Berlin, Germany).
Immunofluorescence staining
Immunostaining of 5hmC and PCNA was performed
using the published method [26]. Briefly, the cells were
plated onto cover slips and treated according to the experi-
mental setup. After 48 h, the cells were fixed with 4 % para-
formaldehyde solution for 15 min at RT and then washed
with PBS. For permeabilization, the cells were incubated
with 0.5 % Triton X-100 in PBS for 15 min at RT. To de-
nature the DNA, the cells were incubated with 4 M HCl
for 15 min at RT, rinsed with distilled water, and placed in
100 mM Tris-HCl (pH 8.5) for 10 min. After washing with
PBS, non-specific binding sites were blocked with blocking
buffer (10 % FCS, 0.1 % Tween-20 in PBS) for 1 h at RT.
Then, the cells were incubated with primary antibodies
such as anti-5hmC rabbit polyclonal IgG (Active Motif,
CA, USA) or anti-PCNA Rabbit mAB (Abcam, Cambridge,
UK) at 1:1000 and 1:200, respectively, in PBS solution con-
taining 1 % FCS and 0.1 % Tween-20 overnight at 4 °C.
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After washing with PBS, the cells were incubated with sec-
ondary antibody solution (ALEXA-Fluor antibodies, Invi-
trogen, NY, USA), diluted 1:400 in PBS solution containing
1 % FCS and 0.1 % Tween-20 for 1 h at RT. Nuclei were
counterstained by incubation with Hoechst 33342 solution
(2 μg/ml in PBS) for 10 min at RT. After a final washing
step with PBS, the stained cells were mounted with a
mounting medium (Fluoromount G, Southern Biotech, NJ,
USA). Images of the staining were taken with an EVOS
fluorescence microscope (AMG, Life technologies, MA,
USA) processed and analyzed with Image J 1.45s software
(NIH, USA) [27].
Real-time RT-PCR for detection of mRNA expression
Real-time PCR was performed as described previously [8].
Briefly, for the mRNA expression studies, total RNA was
extracted using TriFast reagent (Peqlab, Erlangen,
Germany); 2–3 μg of the total RNA was digested with
DNase I in order to eliminate the contaminating genomic
DNA according to the manufacturer’s instructions
(Thermo Scientifics, CA, USA). Complementary DNA
(cDNA) was synthesized by First Strand cDNA Synthesis
Kit (Thermo Scientifics, CA, USA). For quantitative real-
time PCR (qRT-PCR), 40 ng of template cDNA was used
for the expression level of each target gene (primer se-
quences are listed in Table 1) using SYBR Green qPCR
(Thermo scientific, Waltham, MA, USA) and the Step
One Plus® Real-Time PCR System Kit (Life technologies,
Carlsbad, CA, USA). All genes examined were normalized
to a housekeeping gene encoding GAPDH. Relative expres-
sion values were calculated from Ct values using the ΔΔCT
method with untreated cells as a control. Fold induction
was calculated according to the formula 2(Rt − Et)/2(Rn− En)
[28]. PCRs were performed as follows: denaturation for
10 min at 95 °C, amplification with 40 cycles and 15 s at
95 °C, 40 s at 60 °C, and 15 s at 72 °C (Step One Plus™
Real-Time PCR System, Life technologies, CA, USA). The
primer sequences are listed in Table 1. Each sample was set
up in triplicates, and the experiment was repeated at least
twice. Statistical significance of difference in target genes
expression level between different treatment was assessed
by t test, at α = 0.05.
Resazurin conversion, LDH leakage, and FACS
measurement
To investigate the impact of 5-AZA together with vitamin
C on cell proliferation, the cells were incubated with differ-
ent doses of 5-AZA and vitamin C at different time points.
Cell viability (mitochondrial activity) was determined by
resazurin conversion as described previously [8]. Briefly, 1/
10 volume of the resazurin stock solution (0.025 % in
DPBS) was added to the cells. After 30-min incubation at
37 °C, fluorescence was measured (Ex/Em= 544/590 nm)
and corrected to background control (solvent mixture with-
out cells) on a FLUOstar Omega microplate reader (BMG
Labtech, Germany). Viability is given as percentage of con-
trol (untreated cells).
Lactose dehydrogenase (LDH), released into cell cul-
ture media as index of cell death, was measured using
an LDH Assay Kit from Thermo Scientific (Rockford,
USA) according to the manufacturer’s protocol. LDH re-
leased into the media was expressed as the percentage of
the total cellular LDH per well measured after cells had
been lysed with lysis buffer provided with the kit.
Cell cycle analysis and quantification of hypodiploid
cells was determined by flow cytometry (FC). For FC
analysis, 1 × 106 HCC cells per well were seeded in 6-
well plates and treated with different concentrations of
5-AZA and vitamin C. After 48 h, the cells were fixed in
70 % of ethanol for at least 1 h and stained in a hypo-
tonic solution with 100 μg/ml of RNase and 50 μg/ml
propidium iodide (PI) for 15 min in RT [29]. Distribu-
tion of cells in the different phases of the cell cycle based
on the differences in DNA contents was determined
using a flow cytometer (BD Biosciences, Heidelberg,
Germany). Data were analyzed using Modfit software.
Western blot
The treated and non-treated control cells were harvested
after 48 h and lysed in ice-cold RIPA lysis buffer (50 mM
Tris; 250 mM NaCl; 2 % Nonidet-P40; 2.5 mM EDTA;
Table 1 Primer sequences for real-time PCR
Gene bank ID Forward primer Reverse primer Product length (bp)
TET1 NM_030625.2 TCTGTTGTTGTGCCTCTGGA GCCTTTAAAACTTTGGGCTTC 77
TET2 NM_001127208.2 GAGACGCTGAGGAAATACGG TGGTGCCATAAGAGTGGACA 258
TET3 NM_001287491.1 CCCACAAGGACCAGCATAAC CCATCTTGTACAGGGGGAGA 129
SNAIL NM_005985.3 ACCACTATGCCGCGCTCTT ′GGTCGTAGGGCTGCTGGAA 115
E-cadherin NM_004360.3 GTCAGTTCAGACTCCAGCCC AAATTCACTCTGCCCAGGACG 254
GAPDH NM_002046.4 TGCACCACCACTGCTTAGC GGCATGGACTGTGGTCATGAG 87
P21 NM_001291549.1 GTCACTGTCTTGTACCCTTGTG CGGCGTTTGGAGTGGTAGAAA 221
Gadd45 NM_015675.3 GTGTACGAGTCGGCCAAGTT GTCACAGCAGAAGGACTGG- 135
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0.1 % SDS; 0.5 % DOC; complete protease inhibitor; 1.0 %
phosphatase inhibitor; pH 7.2). Protein concentration was
determined by micro-Lowry. Thirty micrograms of total
protein was separated by SDS-PAGE and transferred to
nitrocellulose membranes (Roth, Karlsruhe, Germany).
The membranes were blocked by 5 % blocking buffer
(milk powder in Tris-buffered saline Tween (TBST)) for
1 h and incubated overnight with Snail, GADD48B, P21,
cyclin B1, E-cadherin, TET2, TET3, and GAPDH mouse/
rabbit polyclonal primary antibodies at 4 °C. The following
day, the membranes were incubated with the correspond-
ing HRP-labeled secondary antibodies for 1 h at RT.
Chemiluminescent signals were detected with the Chemo-
Cam (INTAS, Göttingen, Germany).
Protein depletion by siRNAs
Depletion of TET2 and TET3 was achieved by small
interfering RNA (siRNA) approach as reported previ-
ously [8]. Briefly, the HLE and Huh7 cells were trans-
fected with TET2 and TET3 siRNAs, subsequently the
transfected cells were treated with 5-AZA and vitamin C
and harvested after 48 h along with appropriate negative
controls that were transfected with scrambled siRNA.
RNA isolated from treated knock-downs (KDs) and
treated and untreated siRNA controls were used for
gene expression analysis.
Statistical analysis
Statistical significance of differences between the individ-
ual treatments was evaluated by one-way ANOVA Tukey’s
test (Prism 5.01, GraphPad Software, San Diego, USA).
Data are means ± SEM of three independent experiments.
All statistical comparisons were performed two-sided in
the sense of an exploratory data analysis using 0.05 (*),
0.01 (**), and 0.001 (***) level of significance.
Results
Vitamin C enhances the cytotoxic effects of 5-AZA and in-
duces cell death
The viability of the treated HCC cells was assessed as a
function of mitochondrial activity by resazurin conversion
assay and compared to the non-treated control cells. A re-
duced mitochondrial activity, reflecting a decrease in cell
viability, was observed in the HLE and Huh7 cells treated
with 5-AZA both with and without vitamin C, whereas
vitamin C alone did not compromise the mitochondrial
function after 48 h (Fig. 1a). In Huh7, cell viability was fur-
ther reduced when 5-AZA was supplemented with vita-
min C (approximately 30 %) (Fig. 1a).
In both, HLE and Huh7, inhibition of proliferation was
paralleled by increased intracellular LDH enzyme release,
indicating a leakage of intracellular contents by a com-
promise on the membrane integrity and induction of cell
damage after 48 h of treatment (Fig. 1b). While a very low
release of LDH was observed with 5-AZA and vitamin C
individually, the combination of 5-AZA and vitamin C
showed a high rate of cytotoxicity in both cell lines.
Further, flow cytometry analysis of the sub2N popula-
tion as a measure of cell death revealed that the combin-
ation of 5-AZA and vitamin C induced a higher number
of cells in the sub2N in HLE than in solely 5-AZA
treated cells (Fig. 1c). In Huh7, a significant increase in
the sub2N population was observed in cells treated with
5-AZA + vitamin C, with a slight increase in LDH com-
pared to the 5-AZA single-treated cells (Fig. 1c).
Inhibition of cell proliferation and induction of cell cycle
arrest enhanced by the combined treatment of 5-AZA
and vitamin C
To confirm the anti-proliferative effect of 5-AZA and
vitamin C, expression of proliferation cell nuclear anti-
gen (PCNA) was investigated by immunofluorescence
staining (Fig. 2a). In comparison with the untreated con-
trol, inhibition of cell proliferation was observed in the
HLE and Huh7 cells treated with vitamin C (Fig. 2a). In
HLE, 5-AZA treatment induced a significantly higher in-
hibition, which was further enhanced with the combin-
ation treatment of 5-AZA + vitamin C. Similarly, in
Huh7, a significant inhibition of proliferation was ob-
served with both 5-AZA and the combination of 5-AZA
+ vitamin C (Fig. 2a).
Next, we determined by flow cytometry the phase of
the cell cycle where the observed growth inhibition in
both cell lines occurred. Cell cycle distribution analysis
of the HLE cells treated with 5-AZA and vitamin C indi-
vidually indicated an increase in the population of cells
in G2 phase. However, a stronger increase in the S phase
of the cell cycle was noted in cells treated with a com-
bination of 5-AZA + vitamin C (Fig. 2b). In Huh7, we
observed an increase in the population of cells in the G1
phase of the cell cycle with 5-AZA and vitamin C treat-
ment. However, the number of cells in the G1 phase was
highest with the combination treatment of 5-AZA and
vitamin C (Fig. 2b).
Vitamin C improves the efficacy of 5-AZA in TET-
dependent active demethylation in HCC cell lines
In order to further evaluate the changes in the expression of
genes which could have led to the cell cycle arrest, we first
studied if the combination of 5-AZA and vitamin C induces
any epigenetic changes in HCC cells. Since 5-AZA and vita-
min C are both known to induce active demethylation
which reflects changes in the 5hmC status [8, 11, 13, 14],
we investigated the 5hmC content of the HCC cell lines
treated with 5-AZA, vitamin C, and the combination of
both after 48 h. Immunofluorescence (IF) staining of 5hmC
indicated the presence of a significantly high percentage of
5hmc-positive cells with the combined treatment as
Sajadian et al. Clinical Epigenetics  (2016) 8:46 Page 4 of 13
compared to each single treatment in both HLE and Huh7
(Fig. 3a). The cells treated with vitamin C alone also showed
an increase in 5hmC as compared to 5-AZA treatment or
the untreated control, underlining the important role of
vitamin C in active demethylation.
To investigate whether the effect of this increase in
5hmC intensity after treatment was correlated with
changes in TET2 and TET3, the mRNA level of TET2
and TET3 was determined by real-time PCR. The cells
treated with the combination of 5-AZA and vitamin C
demonstrated a significantly increased expression of
TET2 and TET3 as compared to the individually treated
and non-treated controls in both HLE and Huh7
(Fig. 3b). In the Huh7 cells, vitamin C alone enhanced
the expression of TET2 and TET3 while 10 μM of 5-
AZA could not induce a significant increase in the
Fig. 1 Vitamin C enhances the cytotoxic effects of 5-AZA in inducing cell death in HCC. a Changes in the resazurin conversion indicating the cell
viability in HLE and Huh7 cells treated with vitamin C, 5-AZA, and 5-AZA + vitamin C compared to the untreated controls after 48 h. b Changes in the
LDH release by HLE and Huh7 with the various treatments compared to the untreated control. c Flow cytometric measurement of sub2N population
in HLE and Huh7 treated with vitamin C, 5-AZA, and 5-AZA + vitamin C. All the data are the average of the experiments (N = 3). Statistical significance
was tested using one-way ANOVA (non-parametric) Tukey’s test. *p≤ 0.05; **p≤ 0.01; ***p≤ 0.01. Error bars represent the standard deviation
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expression of TET2 and TET3 (Fig. 3b). These data indi-
cate the possibility that vitamin C when combined to-
gether with 5-AZA could influence the conversion of
5mC to 5hmC by inducing TET2 and TET3 expression.
Our Western blot data also confirmed the increase of
TET2 and TET3 after stimulation with 5-AZA and vita-
min C (Fig. 3c).
Induction of active demethylation by 5-AZA and vitamin
C leads to downregulation of Snail and activation of
GADD45B
Snail is a transcription factor regulated by methylation
and has an important role in mediating EMT and in in-
ducing tumorigenesis [21, 30]. Therefore, we first evalu-
ated the effect of 5-AZA and vitamin C on Snail
expression.
Our results show that the HLE cells treated with
vitamin C or 5-AZA individually show only small
changes in the expression of mRNA and protein, while
the combination of both substances results in a sig-
nificant reduction of both Snail mRNA and protein
levels (Fig. 4a, c).
In the Huh7 cells, a significant decrease in the mRNA
was noted with vitamin C and 5-AZA independently and
with a combination of 5-AZA + vitamin C while a corre-
sponding decrease in protein was observed only with 5-
AZA and the combination of 5-AZA + vitamin C
(Fig. 4a, c).
We next studied the expression of the DNA damage-
inducible gene GADD45B which is involved in G1 or G2
cell cycle arrest [31] and which has been implicated in/has
been linked to the progression of HCC [32, 33]. We
investigated whether the combined treatment of 5-
AZA and vitamin C resulted in altered expression of
GADD45B.
In both HLE and Huh7, an increase in GADD45B tran-
scripts and proteins was observed with vitamin C and 5-
AZA independently, but the increase was significant only
with the combined treatment of 5-AZA + vitamin C
(Fig. 4b, c). However, the combination of 5-AZA and vita-
min C induced GADD45B mRNA and protein in both the
HCC cell lines (Fig. 4b, c).
Further, to investigate whether the observed changes
in the expression of Snail and GADD45 are TET-
dependent, quantification of Snail and GADD45B
Fig. 2 5-AZA and vitamin C inhibit cell proliferation and induce cell cycle arrest in HCC. a PCNA nuclear staining of HCC cell lines, HLE and Huh7,
treated with vitamin C, 5-AZA, and 5-AZA + vitamin C for 48 h. Graphs represent the calculation of the percentage of PCNA-positive cells
as an indicator of inhibition of cell proliferation in HLE and Huh7. b Cell cycle analysis indicating the stage of cell cycle arrest in HLE and
Huh7. All the data are the average of the experiments (N = 3). Statistical significance was tested using one-way ANOVA (non-parametric)
Tukey’s test. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.01. Error bars represent the standard deviation
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transcripts was done in TET2 and TET3 KD of the
HLE and Huh7 cells treated with 5-AZA + vitamin C.
While Snail expression is downregulated in the
SiRNA control, in the TET2 and TET3 KDs, an in-
crease in the expression of Snail in HLE and Huh7
was observed with the treatment (Fig. 4d). Similar
results were observed with GADD45B, where an in-
crease in GADD45B expression was seen in the
SiRNA controls treated with 5-AZA + vitamin C,
however, within the TET2 and TET3 KDs, an increase
in the expression of GADD45B was seen with the
treatment of 5-AZA + vitamin C (Fig. 4e).
Fig. 3 Vitamin C enhances the efficacy of 5-AZA in inducing active demethylation and generation of 5hmc by induction of TET expression in HCC.
a 5hmC nuclear staining of HCC cell lines, HLE and Huh7, treated with vitamin C, 5-AZA, and 5-AZA + vitamin C. 5hmC-positive cells are seen in red,
Hoechst is seen in blue. White line represents the scale bar (20 μm). Graphs show the calculation of the percentage of 5hmC-positive cells as an indicator
of active demethylation in HLE and Huh7. b Quantitative changes in the mRNA expression of TET2 and TET3 in HLE and Huh7 cells with the
various treatments. Data was normalized using GAPDH expression as a reference control. c Western blot results show changes of TET2 and
TET3 protein expression in HLE and Huh7 cells with the various treatments. Data was normalized using GAPDH expression as a reference control. All
the data are the average of the experiments (N = 3). Statistical significance was tested using one-way ANOVA (non-parametric) Tukey’s test. *p≤ 0.05;
**p≤ 0.01; ***p≤ 0.01. Error bars represent the standard deviation
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Upregulated p21 and downregulated cyclin B1 expression
induce cell cycle arrest
In the HLE and Huh7 cells, a significant upregulation of
P21 mRNA was noted by the combination of 5-AZA +
vitamin C as compared to 5-AZA or vitamin C individual
treatments (Fig. 5a, b). In HLE, 5-AZA and 5-AZA + vita-
min C treatments induced a significant increase in p21
protein, whereas in Huh7, the increase in p21 protein was
higher in the combination treatment of 5-AZA + vitamin
C than with 5-AZA alone. Since Snail represses p21 [34],
it is possible that the increase in p21 may be attributed to
a corresponding decrease in the Snail protein in both HLE
and Huh7 leading to the arrest of the cells in G1, S, and
or G2 phases of the cell cycle.
We also investigated changes in cyclin B1 protein ex-
pression as a downstream target of P21, which is essen-
tial for the progression of cells from G2 to the M phase
of the cell cycle (Fig. 5b, c). In HLE, we observed that
the expression of cyclin B1 decreased with independent
vitamin C treatment but increased with independent 5-
AZA treatment. However again, only the combination of
5-AZA + vitamin C reduced the expression of cyclin B1
significantly. As a consequence of cyclin B1 decrease,
cells in the G2 phase are inhibited to progress to the M
Fig. 4 Vitamin C enhances the downregulation of Snail and upregulation of GADD45B expression induced by 5-AZA in HCC. a Quantitative changes in
Snail mRNA in HLE and Huh7 treated with vitamin C, 5-AZA, and 5-AZA + vitamin C compared to the untreated control after 48 h. Data was normalized
using GAPDH expression as a reference control. b Quantitative changes in GADD45B mRNA in HLE and Huh7 with the various treatments after 48 h. Data
was normalized using GAPDH expression as a reference control. c Western blot analysis for changes in Snail and GADD45B proteins in HLE and Huh7
with the various treatments. Calculations were normalized with GAPDH protein as a reference standard. d Snail expression is downregulated in the SiRNA
control; however, in the TET2 and TET3 KDs, an increase in the expression of Snail in HLE and Huh7 was observed with the treatment. All the data are
the average of the experiments (N= 3). e An increase in GADD45B expression was seen in the SiRNA controls treated with 5-AZA + vitamin C; however,
within the TET2 and TET3 KDs, an increase in the expression of GADD45B expression was seen with the treatment with 5-AZA + vitamin C. Statistical
significance was tested using one-way ANOVA (non-parametric),Tukey’s test. *p≤ 0.05; **p≤ 0.01; ***p≤ 0.01. Error bars represent the standard deviation
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phase, which means that cell arrest takes place in the
G2/M phase of the cell cycle. In the Huh7 cell line, how-
ever, we observed a significant decrease in cyclin B1 only
with 5-AZA treatment.
Increased E-cadherin expression indicates a possible shift
of cells towards epithelial phenotype
Snail is a direct repressor of E-cadherin and induces
EMT in HCC [33, 34]. In addition, it was reported that
vitamin C induces MET by induction of TET proteins
which may prevent cancer cells from attaining further
invasive traits [11]. Thus, we were interested whether or
not vitamin C and/or 5-AZA influence E-cadherin ex-
pression in HCC lines. In both HLE and Huh7 cell lines
treated with vitamin C, 5-AZA, and 5-AZA + vitamin C,
we observed an increase in E-cadherin mRNA and pro-
tein expression as compared to the untreated controls
(Fig. 6a, b). In both HCC cell lines, the combination of
5-AZA + vitamin C showed a higher expression than 5-
AZA alone. Further, it was interesting to note that in
both cases, vitamin C independently was also able to in-
duce a high expression of E-cadherin (Fig. 6a, b).
Discussion
In this study, we have shown that vitamin C enhances
the demethylation efficacy of 5-AZA by increasing the
expression of TET2 and TET3 in HCC. In line with
these data, we observed a significant cytotoxic increase
Fig. 5 Increased P21 and reduced cyclin B1 by 5-AZA and vitamin C in HCC lead to cell cycle arrest. a Quantitative changes in P21 mRNA in HLE
and Huh7 treated with vitamin C, 5-AZA, and 5-AZA + vitamin C compared to the untreated control after 48 h. Data was normalized using GAPDH expression
as a reference control. b Western blot analysis for changes in P21 and cyclin B1 proteins in HLE and Huh7 with various treatments. Calculations
were normalized with GAPDH protein. c Graphs represent the calculation of changes in cyclin B1 protein in HLE and Huh7 with the various treatments.
Data was normalized using GAPDH expression as a reference control. All the data are the average of the experiments (N = 3). Statistical significance
was tested using one-way ANOVA (non-parametric) Tukey’s test. *p≤ 0.05; **p≤ 0.01; ***p≤ 0.01. Error bars represent the standard deviation
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when HCC cells were co-incubated with 5-AZA and vita-
min C which is paralleled by an increased inhibition of cell
proliferation, a decreased Snail expression, and an upregu-
lation of the cell division kinase 2 (CDK-2) inhibitor; P21.
The enhanced expression of GADD45B combined with
the changes in expression of cyclin B1 and PCNA induced
cell cycle arrest in HCC (Fig. 6c).
Recently, we have shown a decrease in cell viability
and an increased cell damage in HCC cell lines treated
with 5-AZA in a dose-dependent manner. Furthermore,
Fig. 6 Increased E-cadherin expression in HCC treated with 5-AZA and vitamin C. a Quantitative changes in E-cadherin mRNA in HLE and Huh7
treated with vitamin C, 5-AZA, and 5-AZA + vitamin C compared to the untreated control after 48 h. Data was normalized using GAPDH expression as a
reference control. b Western blot analysis for changes in P21 and cyclin B1 proteins in HLE and Huh7 with various treatments. Calculations
were normalized with GAPDH protein. All the data are the average of the experiments (N = 3). Statistical significance was tested using one-way ANOVA
(non-parametric) Tukey’s test. *p≤ 0.05; **p≤ 0.01; ***p≤ 0.01). Error bars represent the standard deviation. c Vitamin C enhances active demethylation
induced by 5-AZA, in converting 5-methyl cytosine to 5-hydroxymethyl cytosine by increasing the expression of TET2 and TET3. Induced demethylation
leads to decrease in Snail expression and upregulation of GADD45B. Reduced Snail expression leads to upregulation of P21. The network of interactions
between GADD45, P21, cyclin B1, and PCNA leads to the arrest of cells in G1, S, or G2/M phases of the cell cycle. On the other hand, increased
expression of E-cadherin by reduction of Snail leads to the inhibition of EMT
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we observed a significant induction of TET2 and TET3
at a concentration of 20 μM of 5-AZA [8]. It is interest-
ing to note that the combination of 10 μM 5-AZA with
vitamin C showed the same degree of epigenetic changes
(5hmC intensity and TETs expression) like 20 μM 5-
AZA. In the present study, we clearly demonstrated that
vitamin C is able to enhance the epigenetic activity of 5-
AZA, thus compensating for a higher dose of 5-AZA,
necessary to induce cell cycle arrest in HCC.
Dynamic epigenetic changes mark EMT by the indu-
cible expression of Snail [35]. Snail governs cell cycle pro-
gression by repressing P21 [36]. While Snail expression is
essential for tumorigenesis, reduction in Snail expression
in cancer cells is considered essential in limiting tumor
cell progression by inducing cell cycle arrest [20, 21]. A re-
cent study reports that 5-AZA inhibited the inducible
Snail expression in cultured hepatocytes and also suggests
the possible involvement of miR29b in Snail regulation
[37]. Based on these studies and our recent report [8], we
propose that downregulation in Snail expression is mainly
attributed to an increase in TET activity by a combination
of 5-AZA and vitamin C. Further, the combination of 5-
AZA + vitamin C induced an increase in Snail expression
in TET2 and TET3 KD cells of both HLE and Huh7 in
contrast to the decrease in expression which was seen
when TET2 and TET3 were intact. These results further
emphasized that Snail expression was influenced by in-
creased TET2 and/or TET3 activity upon treatment with
5-AZA and vitamin C. It is reported that miRNAs play an
important role in limiting Snail expression [37]. The de-
crease in Snail expression with the treatment, despite the
corresponding increase in TETs suggests that the effect of
TETs on Snail is indirect, with the probable TET mediated
upregulation of miRs or other repressors of Snail up-
stream of the pathway playing a significant role in limiting
Snail expression. The details of this mechanism, however,
are yet to be elucidated.
The growth arrest and DNA damage-inducible GADD45
genes are central players that are upregulated during cellu-
lar stress. Activation of GADD45 results in several pro-
cesses of growth arrest, DNA repair, survival, or apoptosis
(reviewed in [38]). Hypermethylation of the GADD45 pro-
moter is found in various cancers including HCCs, which
leads to downregulation of GADD45 expression and pro-
motes tumor progression [32, 38]. It was reported that 5-
AZA enhances the expression of GADD45 in colon cancer
cells resulting in the induction of apoptosis [22]. GADD45
proteins are also reported to induce cell cycle arrest by dir-
ect interaction with P21, PCNA, and cyclin B1 (through
CDK1/cyclin B1 complex) thereby inducing cell cycle ar-
rest at the various phases of the cell cycle [39–41]. P21 is
also known to have a PCNA-binding domain towards its
carboxyl terminal and to inhibit the replication of DNA at
the S phase [42]. In the same line of evidence, it was also
reported that binding of P21 to PCNA induces cell cycle
arrest at the G1 or G2 level [43]. In agreement with the
above reports, we have seen an enhanced expression of
GADD45 in our HCC cells treated with a combination of
5-AZA and vitamin C. It has been reported recently that
GADD45 could also induce active demethylation processes
via nucleotide excision repair or base excision repair path-
way [44] which might also be associated with the induction
of active demethylation via 5-AZA and vitamin C, as
shown in this study.
The most common problem associated with tumor cells
is their increased resistance to programmed cell death. In-
duction of E-cadherin expression is considered an import-
ant step in sensitizing tumor cells towards apoptosis [45].
E-cadherin modulates apoptosis by coupling with the
death receptors DR4/DR5. Consequently, increased ex-
pression of E-cadherin sensitizes cancerous cells to cell
death [46]. Therefore, reactivation of E-cadherin could be
an important target for epigenetic therapy in HCC. 5-
AZA, when used either alone or in combination with
other drugs, was shown to enhance the expression of E-
cadherin in HCC cell lines and lung epithelial cells, re-
spectively [45]. In differentiated hepatocytes, 5-AZA not
only maintains the expression but also inhibits downregu-
lation of E-cadherin [37]. In the present study, since Snail
is a direct repressor of E-cadherin [16], reduction of Snail
was expected to have an enhanced expression of E-
cadherin. In line with this, we observed an increase in the
expression of E-cadherin by a combination of 5-AZA +
vitamin C. An increase in the number of cells undergoing
cell death with the combined treatment is probably due to
both the arrest of cells by reduced Snail and the increased
sensitivity of the cells towards cell death by the enhanced
expression of E-cadherin.
An increase in E-cadherin expression upon independent
treatment with vitamin C further highlights the role of
vitamin C in epigenetic regulation. The use of vitamin C
could therefore support the maintenance of epithelial
morphology of the cells and thus prevent the MET, which
is involved in cancer cell invasion and progression [47].
Conclusions
Epigenetics plays a crucial role in tumorigenesis by
modulating EMT and cell cycle proliferation pathways.
We have shown that vitamin C enhances the demethyla-
tion activity of the epigenetic drug 5-AZA and induces
cell cytotoxicity. Inhibition of Snail expression leads to
upregulation of p21 and simultaneous activation of
GADD45 which are considered as the major effectors in
inducing cell cycle arrest, as shown in the HCC cell lines
treated with 5-AZA and vitamin C (Fig. 6c). Our study
has added value to the growing evidences of vitamin C
as an epigenetic player. Though further studies are yet
warranted, our results suggest the possible exploration
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of the use of epigenetic drugs in combination therapies
as an attractive future strategy for cancer treatment.
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